Microfluidics Market by Material (Glass-based, Polymer-based, Silicon-based), Component (Micro Needle, Micro Pump, Microfluidic Chip), Application, End User - Global Forecast 2024-2030

[186 Pages Report] The Microfluidics Market size was estimated at USD 25.53 billion in 2023 and expected to reach USD 31.84 billion in 2024, at a CAGR 25.37% to reach USD 124.31 billion by 2030.

Microfluidics is a multidisciplinary scientific field that deals with the precise control, manipulation, and analysis of fluids at a microscale level, typically in microliters to picoliters. Microfluidics integrates principles from diverse disciplines such as physics, engineering, chemistry, and biology to facilitate operations on small volumes of fluids using microfabricated devices featuring channels with dimensions ranging from tens to hundreds of micrometers. Increasing global investments in life sciences research have accelerated the demand for innovative tools and technologies. Microfluidic devices offer advantages such as high throughput screening capabilities and precise control over fluid handling at low volumes, making them attractive tools for researchers. Advances in healthcare infrastructure focusing on precision medicine have also contributed to an increased adoption of microfluidic technologies for diagnostic purposes. However, the complexity associated with designing, fabricating, and integrating microfluidic devices into current laboratory workflows and standardization issues arising due to different fabrication methods significantly impedes the usage of microfluidics. In addition, manufacturers focus on developing wearable diagnostic devices that employ microfluidic technologies to monitor patients' health in real-time.

In the Americas, the United States and Canada emerged as key players in the microfluidics market due to their robust healthcare infrastructure and strong focus on research, which has led to increased investment from the public and private sectors. The National Institutes of Health (NIH) invests heavily in microfluidics research to advance personalized medicine and develop innovative diagnostic solutions. Countries such as China, Japan, and India showcase immense growth potential in microfluidics in the Asia-Pacific region. In China, numerous research institutions backed by government initiatives focus on developing novel microfluidic platforms for applications such as clinical diagnostics and environmental monitoring. European Union (EU) countries contribute significantly to developing microfluidics technologies, with numerous academic institutions working closely with industries for commercialization. The MEA region is developing interest in adopting cutting-edge medical technologies, including microfluidics, for diagnostic purposes. Countries, including Saudi Arabia and the UAE, have invested in state-of-the-art healthcare facilities that utilize advanced tools such as lab-on-a-chip systems for rapid disease detection.

The market dynamics represent an ever-changing landscape of the Microfluidics Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

• Market Drivers
  • Growing Incidence of Chronic Diseases and Increasing Demand for Point-Of-Care Testing
  • Improved Portability of Devices through Microfluidic Chip Miniaturization and Faster Turn-Around Time for Analysis
  • Potential Applications of Drug Delivery using Microfluidics
• Market Restraints
  • Complicated and Time-Consuming Regulatory Approval Process
• Market Opportunities
  • Development of Microfluidic-Based 3D Cell Culture Systems such as Organ-on-a-Chip
  • Advances in Microfluidic Components for Biomedical Analysis and Diagnostics
• Market Challenges
  • Integration of Microfluidics with Existing Workflows

• Material: Increasing use of glass and silicon-based materials for microfluidic devices

  Glass is preferred for microfluidic devices due to its excellent optical transparency properties, high chemical resistance, and biocompatibility. Polymer-based microfluidic devices offer advantages such as lower manufacturing costs, ease of fabrication through techniques, and flexibility in design. Silicon is widely used in microelectronics and is ideal for integrating sensors, actuators, and other microelectromechanical systems (MEMS) components. Silicon-based microfluidics offer advantages such as high dimensional accuracy, low surface roughness, and compatibility with standard semiconductor fabrication processes.

• Component: Adoption of microneedles and pumps for minimal risk of infection

  Microneedles are minimally invasive devices for various medical applications such as drug delivery, vaccination, and diagnostics. The need-based preference for microneedles is driven by painless drug administration, minimal risk of infection, and reduced tissue damage compared to traditional hypodermic needles. Micropumps are essential in microfluidics, enabling fluid transportation, metering, and mixing at the microscale. Microfluidic chips are the backbone of microfluidic systems, enabling the integration of various components to perform complex fluid manipulation tasks.

The porter's five forces analysis offers a simple and powerful tool for understanding, identifying, and analyzing the position, situation, and power of the businesses in the Microfluidics Market. This model is helpful for companies to understand the strength of their current competitive position and the position they are considering repositioning into. With a clear understanding of where power lies, businesses can take advantage of a situation of strength, improve weaknesses, and avoid taking wrong steps. The tool identifies whether new products, services, or companies have the potential to be profitable. In addition, it can be very informative when used to understand the balance of power in exceptional use cases.

The value chain of the Microfluidics Market encompasses all intermediate value addition activities, including raw materials used, product inception, and final delivery, aiding in identifying competitive advantages and improvement areas. Critical path analysis of theMicrofluidics Market identifies task sequences crucial for timely project completion, aiding resource allocation and bottleneck identification. Value chain and critical path analysis methods optimize efficiency, improve quality, enhance competitiveness, and increase profitability. Value chain analysis targets production inefficiencies, and critical path analysis ensures project timeliness. These analyses facilitate businesses in making informed decisions, responding to market demands swiftly, and achieving sustainable growth by optimizing operations and maximizing resource utilization.

The regulatory framework analysis for the Microfluidics Market is essential for ensuring legal compliance, managing risks, shaping business strategies, fostering innovation, protecting consumers, accessing markets, maintaining reputation, and managing stakeholder relations. Regulatory frameworks shape business strategies and expansion initiatives, guiding informed decision-making processes. Furthermore, this analysis uncovers avenues for innovation within existing regulations or by advocating for regulatory changes to foster innovation.

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Microfluidics Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Microfluidics Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

• Astraveus Raises €16.5 Million Series Seed Round to Advance the Development of its Automated, Microfluidic Cell and Gene Therapy Manufacturing Platform

  Astraveus SAS, an innovator in cell and gene therapy (CGT) manufacturing, has emerged from stealth with USD 18.26 million Series Seed financing. The funding round was led by AdBio Partners, co-syndicated with M Ventures, Johnson & Johnson Innovation – JJDC Inc., and Bpifrance Large Venture. Astraveus leverages microfluidic cell foundries known as the Lakhesys platform to enhance CGT manufacturing processes. The Lakhesys system employs deep process optimization and single-use microfluidic bioprocessors to optimize CGT outcomes while minimizing resource utilization. [Published On: July 27, 2023]

• Bio-Techne to acquire Swiss spatial biology firm Lunaphore

  Bio-Techne, a major player in microfluidics, announced its recent acquisition of Lunaphore, a Swiss-based developer of automated spatial biology products. Lunaphore's microfluidic technology offers precise and hyper plex proteomic and transcriptomic biomarkers for tumors and other tissues. This innovative technology provides the necessary data for discovering and developing diagnostic tools in the fields of immunology, immuno-oncology, and neuroscience. By leveraging Lunaphore's advanced solutions, Bio-Techne aims further to advance research and development in these critical areas. [Published On: June 22, 2023]

• CellFE Announces Launch of Novel Microfluidic Cellular Engineering Platform at ASGCT 2023 Annual Meeting

  CellFE Inc., a microfluidics company, launched its Infinity Mtx cellular engineering platform for commercial use. This platform utilizes rapid cell compression and re-expansion techniques to introduce target payloads into cells effectively. The advantages of this platform are that it yields high quantities of edited cells, reduces recovery and expansion times, facilitates efficient uptake of various payloads, and lowers manufacturing expenses. By leveraging these capabilities, CellFE Inc. aims to revolutionize the field of cell therapy and contribute to the development of innovative treatments. [Published On: May 10, 2023]

The report delves into recent significant developments in the Microfluidics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Ascent Bio-Nano Technologies, Inc., Camozzi Automation S.p.A., Dolomite Microfluidics, IMT Masks and Divisions AG, PerkinElmer Inc., Thermo Fisher Scientific, Inc., Mission Bio, Inc., Idex Corporation, NanoCellect Biomedical., Abaxis, Inc., Quidel Corporation, Koninklijke Philips N.V., Parker-Hannifin Corporation, Illumina, Inc., Bio-Rad Laboratories, Inc., BioFluidica, Agilent Technologies, Inc., Danaher Corporation, Biosurfit SA, SMC Corporation, Micropoint Bioscience, Inc., Fluigent S.A., Elvesys Group, Achira Labs Pvt. Ltd., Sphere Fluidics Limited, OPKO Health, Inc., Cellix Limited, AbCellera Biologics Inc., and Fluidigm Corporation by Standard BioTools Inc..

This research report categorizes the Microfluidics Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Material
  • Glass-based
  • Polymer-based
  • Silicon-based
• Component
  • Micro Needle
  • Micro Pump
  • Microfluidic Chip
• Application
  • In-Vitro Diagnostics
    • Clinical Diagnostics
    • Point-Of-Care Testing
    • Veterinary Diagnostics
  • Pharmaceutical & Life Science Research
    • Lab Analytics
      • Capillary Electrophoresis
      • Cell-based Assays
      • Genomic analysis
      • Proteomic Analysis
    • Microdispensing
    • Microreaction
  • Therapeutics
    • Drug Delivery
    • Wearable Devices
• End User
  • Academic & Research Institutes
  • Hospitals & Diagnostic Centers
  • Pharmaceutical & Biotechnology Companies

• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

1. What is the current market size and projected growth?
2. Which products, segments, applications, and regions offer promising investment opportunities?
3. What are the prevailing technology trends and regulatory frameworks?
4. What is the market share and positioning of the leading vendors?
5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?